Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. (Q33899881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marcus W Koch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Helen Tremlett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

B Leung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

S Isserow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

J Geddes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

P Rieckmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

28 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1822-1826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

Mitoxantrone treatment of multiple sclerosis: safety considerations

1 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Treatment of multiple sclerosis with mitoxantrone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Decrease in heart ventricular ejection fraction during multiple sclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20427751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20427751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Liver test abnormalities in multiple sclerosis: Findings from placebo-treated patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20427751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E3181E0F7E6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

20427751

1 reference